Notably, shRNA-mediated perturbation of FTO in pancreatic cancer cells led to alterations in multiple biologically relevant processes associated with pancreatic carcinogenesis, for example, loss of cell growth, motility, and invasiveness. This evidence concerns the gene FTO and familial pancreatic carcinoma.